Advertisement

Topics

SDIX and Novus Biologicals, LLC Company Profile

22:02 EDT 22nd September 2017 | BioPortfolio


News Articles [59 Associated News Articles listed on BioPortfolio]

Australia’s TGA consults on naming of biologicals

Australia’s drug regulatory agency, the Therapeutic Goods Administration (TGA), announced on 28 July 2017 that it was opening a consultation on how to name biologicals.

Biosimilar substitution in Europe

In the European Union (EU), decisions on the interchangeability or substitution of biosimilars and originator biologicals are not made by the European Medicines Agency (EMA), but at the national level...

OriGene to Acquire SDIX's Life Science Business Assets

ROCKVILLE, Md., April 8, 2013 /PRNewswire/ -- OriGene Technologies, Inc., a leading genome wide product company for research and diagnostic applications with operations in the United States and C...

Biosimilars in the treatment of inflammatory bowel disease

Inflammatory bowel disease (IBD) is mainly characterized by two chronic, relapsing, immune-mediated inflammatory diseases of the gastrointestinal tract: Crohn’s disease and ulcerative colitis. Appro...

Novus Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

IRVINE, Calif., June 12, 2017 /PRNewswire/ -- Novus Therapeutics, Inc. (NASDAQ: NVUS) announced today that the Compensation Committee of the Company's Board of Directors approved a grant of inducement...

People's Republic of China Approves Proliant Biologicals for the Importation of New Zealand BSA

ANKENY, Iowa and FEILDING, New Zealand, July 17, 2017 /PRNewswire/ -- Following a recent Chinese decision, centered around New Zealand Origin Bovine Material, Proliant Biologicals is now eligible to s...

Novus Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

  Life Sciences Jobs   ...

Novus Medical Detox Center Release: New Reports Show Rising Gabapentin Misuse And Abuse

R   Life Sciences Jobs   ...

Drugs and Medications [9 Associated Drugs and Medications listed on BioPortfolio]

Human albumin grifols [Instituto Grifols, S.A.]

Albumin (Human) U.S.P. Human Albumin Grifols 20%

Human albumin grifols [Instituto Grifols, S.A.]

Albumin (Human) U.S.P. Human Albumin Grifols 25%

Albutein [Grifols Biologicals Inc.]

These highlights do not include all the information needed to use Albutein 5% safely and effectively. See full prescribing information for Albutein 5%. Albutein 5% [Albumin (Human) U.S.P.] sterile, aq...

Albutein [Grifols Biologicals Inc.]

These highlights do not include all the information needed to use Albutein 20% safely and effectively. See full prescribing information for Albutein 20%. Albutein 20% [Albumin (Human) U.S.P.] sterile,...

Albutein [Grifols Biologicals Inc.]

These highlights do not include all the information needed to use Albutein 25% safely and effectively. See full prescribing information for Albutein 25%.Albutein 25% [Albumin (Human) U.S.P.] sterile, ...

PubMed Articles [31 Associated PubMed Articles listed on BioPortfolio]

Treatment preferences for biologicals in psoriasis: experienced patients appreciate sustainability.

Treatment satisfaction can be improved by integrating patients' preferences into shared decision-making. We recently investigated patients' preferences for attributes of biologicals, and showed high p...

Combining Therapeutic Drug Monitoring with Biosimilars, a Strategy to Improve the Efficacy of Biologicals for Treating Inflammatory Bowel Diseases at an Affordable Cost.

Biologicals provide a tight disease control but not all patients respond favourably to treatment. Some patients do not respond at all (primary non-responders), while other patients respond initially b...

Potential Issues with the Handling of Biologicals in a Hospital.

Dr. Chi-Ming Chu: Respected founder of molecular virology and pioneer of biologicals in China.

Clinical development of biologicals and biosimilars - safety concerns.

Clinical Trials [257 Associated Clinical Trials listed on BioPortfolio]

Non-inferiority of GSK Biologicals' DTPw-HBV/Hib Compared to Two Formulations of GSK Biologicals' DTPw-HBV/Hib

The purpose of this observer-blind study is to generate immunogenicity data with one formulation of GSK Biologicals' DTPw-HBV/Hib vaccine after the primary vaccination course and to demons...

Study of GSK Biologicals' Pandemic Influenza (H1N1) Candidate Vaccine in Children Aged 10 to Less Than 18 Years

The purpose of this study is to show that vaccination with a single dose of GSK Biologicals' pandemic H1N1 vaccine results in an immune response that meets or exceeds European Medicines Ag...

Study to Evaluate GSK Biologicals' GSK2197870A Vaccine Given as Primary Course in Infants

The purpose of this Phase II study is to evaluate the feasibility of GSK Biologicals' GSK2197870A vaccine co-administered with Wyeth-Lederle's Prevenar™ when given in healthy infants as ...

A Safety and Immune Study of 2 Types of GlaxoSmithKline's Varicella Vaccines Given as a 2-doses Course to Healthy Children 12-23 Months of Age.

The purpose of this study is to evaluate the safety and immunogenicity of 2 formulations of GSK Biologicals' varicella vaccines given as a 2-dose course in the second year of life.

Immunogenicity and Safety Study of GSK Biologicals' GSK2202083A Vaccine in Healthy Infants at 2, 3 and 4 Months of Age

This study will evaluate the safety and immunogenicity of GSK Biologicals' GSK2202083A vaccine co-administered with GSK Biologicals' 10-valent pneumococcal conjugate (GSK1024850A) vaccine ...

Companies [57 Associated Companies listed on BioPortfolio]

Novus Biologicals, Inc

The mission of Novus Biologicals, Inc. is to accelerate scientific discovery by marketing unique products in the forefront of science. Novus Biologicals was organized to provide the biological researc...

Novus Biologicals Incorporated

Our mission at Novus Biologicals, Inc. is to supply monoclonal and polyclonal antibodies, recombinant protein and cDNAs for the scientific research community that are of high quality and applicability...

SDIX

SDI is a leading healthcare market insight and analytics firm. It provides the industry’s most comprehensive de-identified patient-level data to pharmaceutical, biotech, reta...

NOVUS INTERNATIONAL

Novus International, Inc., a global leader in the animal agriculture industry, is a privately held corporation headquartered in St. Louis, Missouri. Formed as a joint venture in 1991, the Novus corpor...

Novus International, Inc.

Novus International, Inc. is headquartered in metropolitan St. Louis, Missouri, U.S.A. and serves customers in more than 90 countries around the world. An industry leader in anima...

More Information about "SDIX and Novus Biologicals, LLC" on BioPortfolio

We have published hundreds of SDIX and Novus Biologicals, LLC news stories on BioPortfolio along with dozens of SDIX and Novus Biologicals, LLC Clinical Trials and PubMed Articles about SDIX and Novus Biologicals, LLC for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of SDIX and Novus Biologicals, LLC Companies in our database. You can also find out about relevant SDIX and Novus Biologicals, LLC Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record